Archives of Medical Research·Sep 29Mexican Registry of Dyslipidemias of the Mexican Institute of Social Security: Lipid Profiles in Patients at High and Very High Cardiovascular RiskCross-sectional study in peopleDyslipidemiaPaper
International Journal of Molecular Sciences·Sep 28Features of Lipid Disorders in Cardiovascular-Kidney-Metabolic SyndromeReviewLipid and ceramide metabolismPaper
American Journal of Cardiovascular Disease·Sep 26Residual cardiovascular risk beyond LDL-cholesterol control: what remains unaddressed?ReviewInterventionsPaper
Reports·Sep 24The Utilization of Inclisiran for the Optimization of Lipid Management in People Living with HIV: A Clinical Case Series and Comprehensive ReviewCase seriesInclisiranPaper
Lipids in Health and Disease·Sep 20Real-world use of bempedoic acid for hypercholesterolaemia: a German multicentre, retrospective, cohort studyCohort study of 641 peopleBempedoic acidPaper
Methodist DeBakey Cardiovascular Journal·Sep 19Familial HypercholesterolemiaReviewFamilial hypercholesterolemiaPaper
Journal of Geriatric Cardiology·Sep 19Safety and efficacy of low-density lipoprotein-lowering drugs in the elderly: a network meta-analysis of randomized controlled trialsMeta-analysis of randomized trialsInterventionsPaper
CJC Open·Sep 18Rationale and Design of the Canadian Lipoprotein(a) RegistryCohort study of 127 peoplePopulationsPaper
PLOS One·Sep 15Real world patterns of dyslipidemia care before and after a national fee revision in Japan: A nationwide study using a 30 million patient claims databaseCohort study of 590,000 peopleIndustry & policyPaper
Thrombosis and Haemostasis·Sep 15Statin Intensification and LDL Cholesterol Reduction are Associated with Longitudinal Changes in Circulating Amyloid-β 1-40 in a Prospective Dyslipidemia CohortCohort study of 146 peopleStatinsPaper
Annals of Internal Medicine·Sep 15A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk ReductionCommentaryIndustry & policyPaper
Frontiers in Pharmacology·Sep 11Effects of different statin-based lipid-lowering therapies on stabilization and regression of carotid plaque: a randomized open-label trialRandomized trial in peopleStatinsPaper
Journal of Clinical Lipidology·Sep 9Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysisMeta-analysisStatin + ezetimibePaper
Expert Opinion on Pharmacotherapy·Sep 8Evaluating enlicitide decanoate: first oral PCSK9 inhibitor for the treatment of adults with hypercholesterolemiaReviewEnlicitidePaper
Praxis·Sep 8Dyslipidaemia guideline issued by the Department of Internal Medicine (DIM) at the University Hospital Zurich (USZ)CommentaryIndustry & policyPaper
Frontiers in Medicine·Sep 8Contemporary non-statin therapies for dyslipidemia management: achieving current lipid targetsReviewDyslipidemiaPaper
Open Heart·Sep 7Nationwide LDL-C goal attainment in high-risk and very-high-risk patients in Denmark: real-world lipid management and simulated impact of guideline implementationCohort study of 487,962 peopleInterventionsPaper
Preprints.org·Sep 4Optimizing Cardiovascular Risk in PLWH: Real-World Efficacy and Lipid Kinetics of Fixed-Dose Combination Rosuvastatin/EzetimibePreprint: cohort study of 43 peopleCardiovascular diseasePaper
Endocrinology and Metabolism·Sep 2Ezetimibe Treatment Is Associated with Lower Risk of Incident Cancer: A Nationwide Population-Based Cohort StudyCohort study of 669,036 peopleStatin + ezetimibePaper
European Heart Journal·Aug 31Inclisiran vs bempedoic acid for low-density lipoprotein cholesterol lowering in high-risk patients: the VICTORION-Challenge trialRandomized trial in 402 peopleInclisiranPaper
Laboratory Medicine·Aug 26Review of the American Heart Association PREVENT guidelines: how non-high-density lipoprotein cholesterol and apolipoprotein B fit inComputational studyBiomarkersPaper
Drug Discoveries & Therapeutics·Aug 16Enlicitide: The first oral PCSK9 inhibitor approved for treatment of hypercholesterolemiaTrial in peopleEnlicitidePaper
Russian Journal of Cardiology·Aug 15An integrated approach to a multimorbid patient with extreme risk of cardiovascular events. A case reportInterventionsPaper
PLOS One·Aug 14LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulationComputational studyBempedoic acidPaper
Current Opinion in Cardiology·Aug 13Key advances in secondary prevention after coronary artery bypass graftingReviewCoronary artery diseasePaper
Nutrition, Metabolism, and Cardiovascular Diseases·Aug 11Statin use and LDL cholesterol target attainment in people with HIV after European AIDS Clinical Society 2024 guideline updatesCohort study of 1,379 peoplePopulationsPaper
Journal of Clinical Lipidology·Aug 11Effectiveness, safety, and treatment persistence of bempedoic acid in a Spanish real-world cohortCohort study of 814 peopleBempedoic acidPaper
JACC Advances·Aug 8Opportunistic Genetic Testing for Familial Hypercholesterolemia in Premature Acute Coronary Syndrome: Results of the ACCURATE StudyNon-randomized trial in peopleFamilial hypercholesterolemiaPaper
CNS Drugs·Aug 3Efficacy and Safety of an Early Aggressive Lipid-Lowering Strategy Using Triple Therapy After Mechanical ThrombectomyCohort study of 197 peopleInterventionsPaper